Cationic α-cyclodextrin:poly(ethylene glycol) polyrotaxanes for siRNA delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Molecular Biology

Background:

• RNA interference (RNAi) offers therapeutic potential due to specificity and ability to overcome drug resistance.
• Effective delivery of small interfering RNA (siRNA) remains a challenge in RNAi therapeutics.
• Cationic polyrotaxanes are explored as novel non-viral vectors for nucleic acid delivery.

Purpose of the Study:

• To synthesize and characterize cationic α-cyclodextrin:poly(ethylene glycol) polyrotaxanes for siRNA delivery.
• To evaluate the efficacy and safety of these polyrotaxanes in gene silencing.
• To investigate the influence of polyrotaxane molecular weight on siRNA condensation and delivery.

Main Methods:

• Synthesis of three cationic polyrotaxanes with varying polymer axle molecular weights (2,000, 3,400, and 10,000).
• Characterization of polyrotaxane-siRNA complexes, including particle size (<200 nm) and charge.
• Assessment of cellular internalization, cytotoxicity, and gene silencing efficiency compared to commercial standards (bPEI, Lipofectamine 2000).

Main Results:

• Synthesized polyrotaxanes effectively condensed siRNA into nanoparticles suitable for cellular uptake.
• Cationic polyrotaxanes exhibited significantly lower cytotoxicity (>100-fold) compared to bPEI.
• Comparable gene silencing efficiencies were achieved with Lipofectamine 2000 and bPEI.
• A size-activity relationship was observed, with higher molecular weight polyrotaxanes (PEG3,400 and 10,000) demonstrating superior siRNA condensation and delivery.

Conclusions:

• Cationic polyrotaxanes are promising non-viral vectors for siRNA delivery.
• Higher molecular weight polyrotaxanes enhance siRNA condensation and cellular delivery.
• These novel polyrotaxanes offer a safer and effective alternative for RNAi-based therapeutics.